Difference between revisions of "HAN5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
Line 17: Line 17:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
−
|[[GTS5:Hereditary_papillary_renal_carcinoma_(MET)|Hereditary papillary renal carcinoma (MET)]]
+
|CHAPTER 2 (NASAL, PARANASAL, AND SKULL BASE TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Respiratory_epithelial_adenomatoid_hamartoma|Respiratory epithelial adenomatoid hamartoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Seromucinous_hamartoma|Seromucinous hamartoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Nasal_chondromesenchymal_hamartoma|Nasal chondromesenchymal hamartoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sinonasal_papilloma,_inverted_type|Sinonasal papilloma, inverted type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sinonasal_papilloma,_oncocytic_type|Sinonasal papilloma, oncocytic type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sinonasal_papilloma,_exophytic_type|Sinonasal papilloma, exophytic type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Keratinizing_squamous_cell_carcinoma|Keratinizing squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Non-keratinizing_squamous_cell_carcinoma|Non-keratinizing squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:NUT_carcinoma|NUT carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:SWI/SNF_complex-deficient_sinonasal_carcinoma|SWI/SNF complex-deficient sinonasal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sinonasal_lymphoepithelial_carcinoma|Sinonasal lymphoepithelial carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sinonasal_undifferentiated_carcinoma|Sinonasal undifferentiated carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Teratocarcinosarcoma|Teratocarcinosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:HPV-associated_multiphenotypic_sinonasal_carcinoma|HPV-associated multiphenotypic sinonasal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Intestinal-type_sinonasal_adenocarcinoma|Intestinal-type sinonasal adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Non-intestinal-type_sinonasal_adenocarcinoma|Non-intestinal-type sinonasal adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sinonasal_tract_angiofibroma_|Sinonasal tract angiofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sinonasal_glomangiopericytoma|Sinonasal glomangiopericytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Biphenotypic_sinonasal_sarcoma|Biphenotypic sinonasal sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Chordoma|Chordoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sinonasal_ameloblastoma|Sinonasal ameloblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Meningioma_of_the_sinonasal_tract,_ear,_and_temporal_bone|Meningioma of the sinonasal tract, ear, and temporal bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Olfactory_neuroblastoma|Olfactory neuroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Hairy_polyp|Hairy polyp]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Salivary_gland_anlage_tumour|Salivary gland anlage tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Low-grade_nasopharyngeal_papillary_adenocarcinoma|Low-grade nasopharyngeal papillary adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Nasopharyngeal_carcinoma|Nasopharyngeal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_papilloma_and_papillomatosis|Squamous papilloma and papillomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Laryngeal_and_hypopharyngeal_epithelial_dysplasia|Laryngeal and hypopharyngeal epithelial dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Conventional_squamous_cell_carcinoma|Conventional squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Verrucous_carcinoma_of_the_hypopharynx,_larynx,_trachea,_and_parapharyngeal_space|Verrucous carcinoma of the hypopharynx, larynx, trachea, and parapharyngeal space]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Basaloid_squamous_cell_carcinoma|Basaloid squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Papillary_squamous_cell_carcinoma|Papillary squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Spindle_cell_squamous_carcinoma|Spindle cell squamous carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Adenosquamous_carcinoma|Adenosquamous carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Lymphoepithelial_carcinoma_of_the_larynx|Lymphoepithelial carcinoma of the larynx]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Laryngeal_cartilaginous_tumours|Laryngeal cartilaginous tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Nodular_oncocytic_hyperplasia|Nodular oncocytic hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Lymphoepithelial_sialadenitis|Lymphoepithelial sialadenitis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Pleomorphic_adenoma|Pleomorphic adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Basal_cell_adenoma|Basal cell adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Warthin_tumour|Warthin tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Oncocytoma|Oncocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Salivary_gland_myoepithelioma|Salivary gland myoepithelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Canalicular_adenoma|Canalicular adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cystadenoma_of_the_salivary_glands|Cystadenoma of the salivary glands]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ductal_papillomas|Ductal papillomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sialadenoma_papilliferum|Sialadenoma papilliferum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Lymphadenoma_|Lymphadenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sebaceous_adenoma_|Sebaceous adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Intercalated_duct_adenoma_and_hyperplasia|Intercalated duct adenoma and hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Striated_duct_adenoma|Striated duct adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sclerosing_polycystic_adenoma|Sclerosing polycystic adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Keratocystoma|Keratocystoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Acinic_cell_carcinoma|Acinic cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Secretory_carcinoma|Secretory carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Microsecretory_adenocarcinoma|Microsecretory adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Polymorphous_adenocarcinoma|Polymorphous adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Hyalinizing_clear_cell_carcinoma|Hyalinizing clear cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Basal_cell_adenocarcinoma|Basal cell adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Intraductal_carcinoma_|Intraductal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Salivary_duct_carcinoma|Salivary duct carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Myoepithelial_carcinoma|Myoepithelial carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Epithelial-myoepithelial_carcinoma|Epithelial-myoepithelial carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Mucinous_adenocarcinoma|Mucinous adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sclerosing_microcystic_adenocarcinoma|Sclerosing microcystic adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Carcinoma_ex_pleomorphic_adenoma|Carcinoma ex pleomorphic adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Carcinosarcoma_of_the_salivary_glands|Carcinosarcoma of the salivary glands]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sebaceous_adenocarcinoma|Sebaceous adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Lymphoepithelial_carcinoma|Lymphoepithelial carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_cell_carcinoma|Squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sialoblastoma|Sialoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Salivary_carcinoma_NOS_and_emerging_entities|Salivary carcinoma NOS and emerging entities]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sialolipoma|Sialolipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Necrotizing_sialometaplasia|Necrotizing sialometaplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Multifocal_epithelial_hyperplasia|Multifocal epithelial hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Oral_melanoacanthoma|Oral melanoacanthoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_papilloma|Squamous papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Oral_potentially_malignant_disorders|Oral potentially malignant disorders]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Oral_epithelial_dysplasia|Oral epithelial dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Proliferative_verrucous_leukoplakia|Proliferative verrucous leukoplakia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Submucous_fibrosis|Submucous fibrosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:HPV-associated_oral_epithelial_dysplasia|HPV-associated oral epithelial dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Oral_squamous_cell_carcinoma|Oral squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Verrucous_carcinoma_of_the_oral_cavity_and_mobile_tongue|Verrucous carcinoma of the oral cavity and mobile tongue]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Carcinoma_cuniculatum|Carcinoma cuniculatum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Congenital_granular_cell_epulis|Congenital granular cell epulis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ectomesenchymal_chondromyxoid_tumour|Ectomesenchymal chondromyxoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Melanotic_neuroectodermal_tumour_of_infancy|Melanotic neuroectodermal tumour of infancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Hamartomatous_polyps|Hamartomatous polyps]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_cell_carcinoma,_HPV-associated|Squamous cell carcinoma, HPV-associated]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_cell_carcinoma,_HPV-independent|Squamous cell carcinoma, HPV-independent]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Radicular_cyst|Radicular cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Inflammatory_collateral_cysts|Inflammatory collateral cysts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Surgical_ciliated_cyst|Surgical ciliated cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Nasopalatine_duct_cyst|Nasopalatine duct cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Gingival_cysts|Gingival cysts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Dentigerous_cyst|Dentigerous cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Orthokeratinized_odontogenic_cyst|Orthokeratinized odontogenic cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Lateral_periodontal_cyst_and_botryoid_odontogenic_cyst|Lateral periodontal cyst and botryoid odontogenic cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Calcifying_odontogenic_cyst|Calcifying odontogenic cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Glandular_odontogenic_cyst|Glandular odontogenic cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_keratocyst|Odontogenic keratocyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Adenomatoid_odontogenic_tumour|Adenomatoid odontogenic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_odontogenic_tumour|Squamous odontogenic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Calcifying_epithelial_odontogenic_tumour|Calcifying epithelial odontogenic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastoma,_unicystic|Ameloblastoma, unicystic]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastoma,_extraosseous/peripheral|Ameloblastoma, extraosseous/peripheral]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastoma,_conventional|Ameloblastoma, conventional]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Adenoid_ameloblastoma|Adenoid ameloblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Metastasizing_ameloblastoma|Metastasizing ameloblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontoma|Odontoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Primordial_odontogenic_tumour|Primordial odontogenic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastic_fibroma|Ameloblastic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Dentinogenic_ghost_cell_tumour|Dentinogenic ghost cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_fibroma|Odontogenic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cementoblastoma|Cementoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cemento-ossifying_fibroma|Cemento-ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_myxoma|Odontogenic myxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sclerosing_odontogenic_carcinoma|Sclerosing odontogenic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastic_carcinoma|Ameloblastic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Clear_cell_odontogenic_carcinoma|Clear cell odontogenic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ghost_cell_odontogenic_carcinoma|Ghost cell odontogenic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Primary_intraosseous_carcinoma_NOS|Primary intraosseous carcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_carcinosarcoma|Odontogenic carcinosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_sarcomas|Odontogenic sarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Central_giant_cell_granuloma|Central giant cell granuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Peripheral_giant_cell_granuloma|Peripheral giant cell granuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cherubism|Cherubism]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Simple_bone_cyst|Simple bone cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cemento-osseous_dysplasia|Cemento-osseous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Segmental_odontomaxillary_dysplasia|Segmental odontomaxillary dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Fibrous_dysplasia|Fibrous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Juvenile_trabecular_ossifying_fibroma|Juvenile trabecular ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Psammomatoid_ossifying_fibroma|Psammomatoid ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Familial_gigantiform_cementoma|Familial gigantiform cementoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Osteoma|Osteoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Osteochondroma|Osteochondroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Osteoblastoma|Osteoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Chondroblastoma|Chondroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Osteosarcoma_of_the_jaw|Osteosarcoma of the jaw]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:The_chondrosarcoma_family_of_tumours|The chondrosarcoma family of tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Rhabdomyosarcoma_with_TFCP2_rearrangement_|Rhabdomyosarcoma with TFCP2 rearrangement]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Chondrodermatitis_nodularis_chronica_helicis|Chondrodermatitis nodularis chronica helicis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cystic_chondromalacia|Cystic chondromalacia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Exostosis_(osteoma)_of_the_ear|Exostosis (osteoma) of the ear]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ceruminous_adenoma|Ceruminous adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ceruminous_adenocarcinoma|Ceruminous adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_cell_carcinoma_of_the_external_auditory_canal|Squamous cell carcinoma of the external auditory canal]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Otosclerosis|Otosclerosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cholesteatoma|Cholesteatoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Middle_ear_papilloma|Middle ear papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Vestibular_schwannoma|Vestibular schwannoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Middle_ear_neuroendocrine_tumour|Middle ear neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Endolymphatic_sac_tumour|Endolymphatic sac tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Middle_ear_squamous_cell_carcinoma|Middle ear squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Middle_ear_adenocarcinoma|Middle ear adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Lipomas|Lipomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Liposarcomas|Liposarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Nodular_fasciitis|Nodular fasciitis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 28: Line 1,896:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Multiple_endocrine_neoplasia_type_2_(RET)|Multiple endocrine neoplasia type 2 (RET)]]
+
|[[HAN5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 39: Line 1,907:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Juvenile_polyposis_syndrome_(BMPR1A,_SMAD4)|Juvenile polyposis syndrome (BMPR1A, SMAD4)]]
+
|[[HAN5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 50: Line 1,918:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Hereditary_neuroblastoma_(ALK,_PHOX2B)|Hereditary neuroblastoma (ALK, PHOX2B)]]
+
|[[HAN5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 61: Line 1,929:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Encephalocraniocutaneous_lipomatosis_(FGFR1)|Encephalocraniocutaneous lipomatosis (FGFR1)]]
+
|[[HAN5:Haemangioma|Haemangioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 72: Line 1,940:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Glucagon_cell_hyperplasia_and_neoplasia_(GCGR)|Glucagon cell hyperplasia and neoplasia (GCGR)]]
+
|[[HAN5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 83: Line 1,951:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:McCune-Albright_syndrome_(GNAS)|McCune-Albright syndrome (GNAS)]]
+
|[[HAN5:Lymphangioma|Lymphangioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 94: Line 1,962:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Sturge-Weber_syndrome_(GNAQ)|Sturge-Weber syndrome (GNAQ)]]
+
|[[HAN5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 105: Line 1,973:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]]
+
|[[HAN5:Kaposi_sarcoma|Kaposi sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 116: Line 1,984:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]]
+
|[[HAN5:Angiosarcoma|Angiosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 127: Line 1,995:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Costello_syndrome_(HRAS)|Costello syndrome (HRAS)]]
+
|[[HAN5:Myofibroma|Myofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 138: Line 2,006:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Noonan_syndrome_(Various_genes)|Noonan syndrome (Various genes)]]
+
|[[HAN5:Leiomyoma|Leiomyoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 149: Line 2,017:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Schimmelpenning-Feuerstein-Mims_(HRAS,_KRAS)|Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)]]
+
|[[HAN5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 160: Line 2,028:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Carney_complex_(PRKAR1A,_PDE8B,_PDE11A)|Carney complex (PRKAR1A, PDE8B, PDE11A)]]
+
|[[HAN5:Smooth_muscle_tumour_of_uncertain_malignant_potential|Smooth muscle tumour of uncertain malignant potential]]
 
|Disease
 
|Disease
 
|
 
|
Line 171: Line 2,039:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:PROS_syndrome_(PIK3CA)|PROS syndrome (PIK3CA)]]
+
|[[HAN5:Leiomyosarcoma|Leiomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 182: Line 2,050:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]]
+
|[[HAN5:Rhabdomyoma|Rhabdomyoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 193: Line 2,061:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]]
+
|[[HAN5:Rhabdomyosarcomas|Rhabdomyosarcomas]]
 
|Disease
 
|Disease
 
|
 
|
Line 204: Line 2,072:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:AXIN2-associated_polyposis_(AXIN2)|AXIN2-associated polyposis (AXIN2)]]
+
|[[HAN5:Chondroma|Chondroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 215: Line 2,083:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Serrated_polyposis_(RNF43)|Serrated polyposis (RNF43)]]
+
|[[HAN5:Neurofibroma|Neurofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 226: Line 2,094:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:WT1_related_tumour_predisposition_syndrome_(WT1)|WT1 related tumour predisposition syndrome (WT1)]]
+
|[[HAN5:Schwannoma|Schwannoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 237: Line 2,105:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:WAGR_syndrome_(WT1)|WAGR syndrome (WT1)]]
+
|[[HAN5:Neuromas_|Neuromas]]
 
|Disease
 
|Disease
 
|
 
|
Line 248: Line 2,116:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Multiple_endocrine_neoplasia_type_1_(MEN1)|Multiple endocrine neoplasia type 1 (MEN1)]]
+
|[[HAN5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 259: Line 2,127:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Peutz-Jeghers_syndrome_(STK11)|Peutz-Jeghers syndrome (STK11)]]
+
|[[HAN5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 270: Line 2,138:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]]
+
|[[HAN5:Myxoma_|Myxoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 281: Line 2,149:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]]
+
|[[HAN5:Extraskeletal_myxoid_chondrosarcoma|Extraskeletal myxoid chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 292: Line 2,160:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Naevoid_basal_cell_carcinoma_syndrome_-_Gorlin_syndrome_(PTCH1,_SUFU,_GPR161)|Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)]]
+
|[[HAN5:Synovial_sarcoma|Synovial sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 303: Line 2,171:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:SMO-related_Curry-Jones_syndrome_(SMO)|SMO-related Curry-Jones syndrome (SMO)]]
+
|[[HAN5:GLI1-altered_soft_tissue_tumour_|GLI1-altered soft tissue tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 314: Line 2,182:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:ELP1-related_medulloblastoma_predisposition_syndrome(ELP1)|ELP1-related medulloblastoma predisposition syndrome(ELP1)]]
+
|[[HAN5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 325: Line 2,193:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Osteochondromatosis_(EXT1,_EXT2)|Osteochondromatosis (EXT1, EXT2)]]
+
|[[HAN5:Ewing_sarcoma|Ewing sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 336: Line 2,204:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Brooke-Spiegler_syndrome_(CYLD)|Brooke-Spiegler syndrome (CYLD)]]
+
|[[HAN5:Reactive_lymphoid_hyperplasia|Reactive lymphoid hyperplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 347: Line 2,215:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Tuberous_sclerosis_(TSC1,_TSC1)|Tuberous sclerosis (TSC1, TSC1)]]
+
|[[HAN5:EBV-positive_mucocutaneous_ulcer|EBV-positive mucocutaneous ulcer]]
 
|Disease
 
|Disease
 
|
 
|
Line 358: Line 2,226:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:PTEN_hamartoma_tumour_syndrome_(PTEN)|PTEN hamartoma tumour syndrome (PTEN)]]
+
|[[HAN5:IgG4-related_disease|IgG4-related disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 369: Line 2,237:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Activated_Phosphatidylinositol-3-OH_kinase_δ_Syndrome_-_APDS_(PIK3CD)|Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)]]
+
|[[HAN5:Extramedullary_myeloid_sarcoma|Extramedullary myeloid sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 380: Line 2,248:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Multiple_endocrine_neoplasia_type_5,_MAX_related_tumours_(MAX)|Multiple endocrine neoplasia type 5, MAX related tumours (MAX)]]
+
|[[HAN5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]
 
|Disease
 
|Disease
 
|
 
|
Line 391: Line 2,259:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:MAFA-related_familial_insulinomatosis_(MAFA)|MAFA-related familial insulinomatosis (MAFA)]]
+
|[[HAN5:Mantle_cell_lymphoma|Mantle cell lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 402: Line 2,270:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Birt-Hogg-Dube_syndrome_(FLCN)|Birt-Hogg-Dube syndrome (FLCN)]]
+
|[[HAN5:Follicular_lymphoma|Follicular lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 413: Line 2,281:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Familial_chordoma_(TBXT)|Familial chordoma (TBXT)]]
+
|[[HAN5:Paediatric-type_follicular_lymphoma|Paediatric-type follicular lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 424: Line 2,292:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Hyperparathyroidism_jaw_tumour_syndrome_(CDC73)|Hyperparathyroidism jaw tumour syndrome (CDC73)]]
+
|[[HAN5:Large_B-cell_lymphoma_with_IRF4_rearrangement|Large B-cell lymphoma with IRF4 rearrangement]]
 
|Disease
 
|Disease
 
|
 
|
Line 435: Line 2,303:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Von_Hippel-Lindau_syndrome_(VHL)|Von Hippel-Lindau syndrome (VHL)]]
+
|[[HAN5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 446: Line 2,314:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:SDH-deficient_tumour_syndrome_-_Hereditary_phaeochromocytoma-paraganglioma_syndromes_(SDHA,_SDHB,_SDHC,_SDHD,_SDHAF2)|SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)]]
+
|[[HAN5:Burkitt_lymphoma|Burkitt lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 457: Line 2,325:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome_(FH)|Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)]]
+
|[[HAN5:Plasmacytoma|Plasmacytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 468: Line 2,336:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Hereditary_tyrosinaemia_type_1_(FAH)|Hereditary tyrosinaemia type 1 (FAH)]]
+
|[[HAN5:Plasmablastic_lymphoma|Plasmablastic lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 479: Line 2,347:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Li-Fraumeni_syndrome_(TP53)|Li-Fraumeni syndrome (TP53)]]
+
|[[HAN5:T-lymphoblastic_leukaemia/lymphoma|T-lymphoblastic leukaemia/lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 490: Line 2,358:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]]
+
|[[HAN5:Primary_mucosal_CD30-positive_T-cell_lymphoproliferative_disorder|Primary mucosal CD30-positive T-cell lymphoproliferative disorder]]
 
|Disease
 
|Disease
 
|
 
|
Line 501: Line 2,369:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Multiple_endocrine_neoplasia_type_4_(CDKN1B)|Multiple endocrine neoplasia type 4 (CDKN1B)]]
+
|[[HAN5:Extranodal_NK/T-cell_lymphoma|Extranodal NK/T-cell lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 512: Line 2,380:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:CDKN2A-related_tumour_predisposition_syndrome_(CDKN2A)|CDKN2A-related tumour predisposition syndrome (CDKN2A)]]
+
|[[HAN5:Hodgkin_lymphoma|Hodgkin lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 523: Line 2,391:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:CDK4-related_melanoma_predisposition_syndrome_(CDK4)|CDK4-related melanoma predisposition syndrome (CDK4)]]
+
|[[HAN5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 
|Disease
 
|Disease
 
|
 
|
Line 534: Line 2,402:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Autoimmune_lymphoproliferative_syndrome_(FAS)|Autoimmune lymphoproliferative syndrome (FAS)]]
+
|[[HAN5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 545: Line 2,413:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Lynch_Syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)]]
+
|[[HAN5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 556: Line 2,424:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Muir-Torre_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)]]
+
|[[HAN5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 567: Line 2,435:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]]
+
|[[HAN5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 578: Line 2,446:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]
+
|[[HAN5:Mucosal_melanoma|Mucosal melanoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 589: Line 2,457:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]]
+
|[[HAN5:Ranula|Ranula]]
 
|Disease
 
|Disease
 
|
 
|
Line 600: Line 2,468:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]]
+
|[[HAN5:Lymphoepithelial_cyst|Lymphoepithelial cyst]]
 
|Disease
 
|Disease
 
|
 
|
Line 611: Line 2,479:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Fanconi_anaemia_(FANC_genes)|Fanconi anaemia (FANC genes)]]
+
|[[HAN5:Branchial_cleft_cyst|Branchial cleft cyst]]
 
|Disease
 
|Disease
 
|
 
|
Line 622: Line 2,490:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:MUTYH-associated_polyposis_(MUTYH)|MUTYH-associated polyposis (MUTYH)]]
+
|[[HAN5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]]
 
|Disease
 
|Disease
 
|
 
|
Line 633: Line 2,501:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:NTHL1-related_tumour_syndrome_(NTHL1)|NTHL1-related tumour syndrome (NTHL1)]]
+
|[[HAN5:Dermoid_and_teratoid_cysts|Dermoid and teratoid cysts]]
 
|Disease
 
|Disease
 
|
 
|
Line 644: Line 2,512:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:MBD4-associated_neoplasia_syndrome_(MBD4)|MBD4-associated neoplasia syndrome (MBD4)]]
+
|[[HAN5:Branchioma|Branchioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 655: Line 2,523:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Xeroderma_Pigmentosum|Xeroderma Pigmentosum]]
+
|[[HAN5:Heterotopia-associated_carcinoma|Heterotopia-associated carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 666: Line 2,534:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]]
+
|[[HAN5:Squamous_carcinoma_of_unknown_primary_site|Squamous carcinoma of unknown primary site]]
 
|Disease
 
|Disease
 
|
 
|
Line 677: Line 2,545:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]]
+
|[[HAN5:Germ_cell_tumours_of_the_head_and_neck|Germ cell tumours of the head and neck]]
 
|Disease
 
|Disease
 
|
 
|
Line 688: Line 2,556:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]]
+
|[[HAN5:Metastases_to_the_head_and_neck_region|Metastases to the head and neck region]]
 
|Disease
 
|Disease
 
|
 
|
Line 699: Line 2,567:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Polymerase_proofreading-associated_polyposis_(POLD1,_POLE)|Polymerase proofreading-associated polyposis (POLD1, POLE)]]
+
|[[HAN5:Neuroendocrine_tumour|Neuroendocrine tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 710: Line 2,578:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Bloom_syndrome_(BLM)|Bloom syndrome (BLM)]]
+
|[[HAN5:Ectopic_or_invasive_PitNET_/_pituitary_adenoma|Ectopic or invasive PitNET / pituitary adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 721: Line 2,589:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Werner_syndrome_(WRN)|Werner syndrome (WRN)]]
+
|[[HAN5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 732: Line 2,600:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Rothmund-Thomson_syndrome_(ANAPC1,_RECQL4)|Rothmund-Thomson syndrome (ANAPC1, RECQL4)]]
+
|[[HAN5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 743: Line 2,611:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:DDX41-related_haematologic_tumour_predisposition_syndrome_(DDX41)|DDX41-related haematologic tumour predisposition syndrome (DDX41)]]
+
|[[HAN5:Merkel_cell_carcinoma|Merkel cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 754: Line 2,622:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Mosaic_variegated_aneuploidy_(BUB1B,_CEP57,_TRIP13,_BUB1,_BUB3)|Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)]]
+
|[[HAN5:Head_and_neck_paraganglioma|Head and neck paraganglioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 765: Line 2,633:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Klinefelter_syndrome|Klinefelter syndrome]]
+
|[[HAN5:Naevoid_basal_cell_carcinoma_syndrome_(Gorlin_syndrome)|Naevoid basal cell carcinoma syndrome (Gorlin syndrome)]]
 
|Disease
 
|Disease
 
|
 
|
Line 776: Line 2,644:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Turner_syndrome|Turner syndrome]]
+
|[[HAN5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|Disease
 
|Disease
 
|
 
|
Line 787: Line 2,655:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Down_syndrome|Down syndrome]]
+
|[[HAN5:Familial_adenomatous_polyposis_and_Gardner_syndrome|Familial adenomatous polyposis and Gardner syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 798: Line 2,666:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]]
+
|[[HAN5:Brooke-Spiegler_syndrome|Brooke-Spiegler syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 809: Line 2,677:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]]
+
|[[HAN5:Cowden_syndrome|Cowden syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 820: Line 2,688:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Beckwith-Wiedemann_spectrum_(IGF2;_CDKN1C)|Beckwith-Wiedemann spectrum (IGF2; CDKN1C)]]
+
|[[HAN5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
 
|Disease
 
|Disease
 
|
 
|
Line 831: Line 2,699:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Enchondromatosis_(IDH1,_IDH2)|Enchondromatosis (IDH1, IDH2)]]
+
|[[HAN5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]]
 
|Disease
 
|Disease
 
|
 
|
Line 842: Line 2,710:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Rhabdoid_tumour_predisposition_syndrome_(SMARCB1,_SMARCA4)|Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)]]
+
|[[HAN5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 853: Line 2,721:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Schwannomatosis_(SMARCB1,_LZTR1)|Schwannomatosis (SMARCB1, LZTR1)]]
+
|[[HAN5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 864: Line 2,732:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Clear_cell_meningioma_predisposition_syndrome_(SMARCE1)|Clear cell meningioma predisposition syndrome (SMARCE1)]]
+
|[[HAN5:Fanconi_anaemia|Fanconi anaemia]]
 
|Disease
 
|Disease
 
|
 
|
Line 875: Line 2,743:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Weaver_syndrome_(EZH2)|Weaver syndrome (EZH2)]]
+
|[[HAN5:Dyskeratosis_congenita|Dyskeratosis congenita]]
 
|Disease
 
|Disease
 
|
 
|
Line 886: Line 2,754:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]]
+
|[[HAN5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 897: Line 2,765:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]]
+
|[[HAN5:Bloom_syndrome|Bloom syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 908: Line 2,776:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Goldenhar_syndrome_(MYT1,_SF3B2)|Goldenhar syndrome (MYT1, SF3B2)]]
+
|[[HAN5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 919: Line 2,787:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:BAP1-related_tumour_predisposition_syndrome_(BAP1)|BAP1-related tumour predisposition syndrome (BAP1)]]
+
|[[HAN5:Tuberous_sclerosis|Tuberous sclerosis]]
 
|Disease
 
|Disease
 
|
 
|

Revision as of 14:13, 25 February 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Head and Neck Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CHAPTER 2 (NASAL, PARANASAL, AND SKULL BASE TUMOURS)
Respiratory epithelial adenomatoid hamartoma Disease
Seromucinous hamartoma Disease
Nasal chondromesenchymal hamartoma Disease
Sinonasal papilloma, inverted type Disease
Sinonasal papilloma, oncocytic type Disease
Sinonasal papilloma, exophytic type Disease
Keratinizing squamous cell carcinoma Disease
Non-keratinizing squamous cell carcinoma Disease
NUT carcinoma Disease
SWI/SNF complex-deficient sinonasal carcinoma Disease
Sinonasal lymphoepithelial carcinoma Disease
Sinonasal undifferentiated carcinoma Disease
Teratocarcinosarcoma Disease
HPV-associated multiphenotypic sinonasal carcinoma Disease
Intestinal-type sinonasal adenocarcinoma Disease
Non-intestinal-type sinonasal adenocarcinoma Disease
Sinonasal tract angiofibroma Disease
Sinonasal glomangiopericytoma Disease
Biphenotypic sinonasal sarcoma Disease
Chordoma Disease
Sinonasal ameloblastoma Disease
Adamantinomatous craniopharyngioma Disease
Meningioma of the sinonasal tract, ear, and temporal bone Disease
Olfactory neuroblastoma Disease
Hairy polyp Disease
Salivary gland anlage tumour Disease
Low-grade nasopharyngeal papillary adenocarcinoma Disease
Nasopharyngeal carcinoma Disease
Squamous papilloma and papillomatosis Disease
Laryngeal and hypopharyngeal epithelial dysplasia Disease
Conventional squamous cell carcinoma Disease
Verrucous carcinoma of the hypopharynx, larynx, trachea, and parapharyngeal space Disease
Basaloid squamous cell carcinoma Disease
Papillary squamous cell carcinoma Disease
Spindle cell squamous carcinoma Disease
Adenosquamous carcinoma Disease
Lymphoepithelial carcinoma of the larynx Disease
Laryngeal cartilaginous tumours Disease
Nodular oncocytic hyperplasia Disease
Lymphoepithelial sialadenitis Disease
Pleomorphic adenoma Disease
Basal cell adenoma Disease
Warthin tumour Disease
Oncocytoma Disease
Salivary gland myoepithelioma Disease
Canalicular adenoma Disease
Cystadenoma of the salivary glands Disease
Ductal papillomas Disease
Sialadenoma papilliferum Disease
Lymphadenoma Disease
Sebaceous adenoma Disease
Intercalated duct adenoma and hyperplasia Disease
Striated duct adenoma Disease
Sclerosing polycystic adenoma Disease
Keratocystoma Disease
Mucoepidermoid carcinoma Disease
Adenoid cystic carcinoma Disease
Acinic cell carcinoma Disease
Secretory carcinoma Disease
Microsecretory adenocarcinoma Disease
Polymorphous adenocarcinoma Disease
Hyalinizing clear cell carcinoma Disease
Basal cell adenocarcinoma Disease
Intraductal carcinoma Disease
Salivary duct carcinoma Disease
Myoepithelial carcinoma Disease
Epithelial-myoepithelial carcinoma Disease
Mucinous adenocarcinoma Disease
Sclerosing microcystic adenocarcinoma Disease
Carcinoma ex pleomorphic adenoma Disease
Carcinosarcoma of the salivary glands Disease
Sebaceous adenocarcinoma Disease
Lymphoepithelial carcinoma Disease
Squamous cell carcinoma Disease
Sialoblastoma Disease
Salivary carcinoma NOS and emerging entities Disease
Sialolipoma Disease
Necrotizing sialometaplasia Disease
Multifocal epithelial hyperplasia Disease
Oral melanoacanthoma Disease
Squamous papilloma Disease
Oral potentially malignant disorders Disease
Oral epithelial dysplasia Disease
Proliferative verrucous leukoplakia Disease
Submucous fibrosis Disease
HPV-associated oral epithelial dysplasia Disease
Oral squamous cell carcinoma Disease
Verrucous carcinoma of the oral cavity and mobile tongue Disease
Carcinoma cuniculatum Disease
Congenital granular cell epulis Disease
Granular cell tumour Disease
Ectomesenchymal chondromyxoid tumour Disease
Melanotic neuroectodermal tumour of infancy Disease
Hamartomatous polyps Disease
Squamous cell carcinoma, HPV-associated Disease
Squamous cell carcinoma, HPV-independent Disease
Radicular cyst Disease
Inflammatory collateral cysts Disease
Surgical ciliated cyst Disease
Nasopalatine duct cyst Disease
Gingival cysts Disease
Dentigerous cyst Disease
Orthokeratinized odontogenic cyst Disease
Lateral periodontal cyst and botryoid odontogenic cyst Disease
Calcifying odontogenic cyst Disease
Glandular odontogenic cyst Disease
Odontogenic keratocyst Disease
Adenomatoid odontogenic tumour Disease
Squamous odontogenic tumour Disease
Calcifying epithelial odontogenic tumour Disease
Ameloblastoma, unicystic Disease
Ameloblastoma, extraosseous/peripheral Disease
Ameloblastoma, conventional Disease
Adenoid ameloblastoma Disease
Metastasizing ameloblastoma Disease
Odontoma Disease
Primordial odontogenic tumour Disease
Ameloblastic fibroma Disease
Dentinogenic ghost cell tumour Disease
Odontogenic fibroma Disease
Cementoblastoma Disease
Cemento-ossifying fibroma Disease
Odontogenic myxoma Disease
Sclerosing odontogenic carcinoma Disease
Ameloblastic carcinoma Disease
Clear cell odontogenic carcinoma Disease
Ghost cell odontogenic carcinoma Disease
Primary intraosseous carcinoma NOS Disease
Odontogenic carcinosarcoma Disease
Odontogenic sarcomas Disease
Central giant cell granuloma Disease
Peripheral giant cell granuloma Disease
Cherubism Disease
Aneurysmal bone cyst Disease
Simple bone cyst Disease
Cemento-osseous dysplasia Disease
Segmental odontomaxillary dysplasia Disease
Fibrous dysplasia Disease
Juvenile trabecular ossifying fibroma Disease
Psammomatoid ossifying fibroma Disease
Familial gigantiform cementoma Disease
Osteoma Disease
Osteochondroma Disease
Osteoblastoma Disease
Chondroblastoma Disease
Chondromyxoid fibroma Disease
Desmoplastic fibroma of bone Disease
Osteosarcoma of the jaw Disease
The chondrosarcoma family of tumours Disease
Mesenchymal chondrosarcoma Disease
Rhabdomyosarcoma with TFCP2 rearrangement Disease
Chondrodermatitis nodularis chronica helicis Disease
Cystic chondromalacia Disease
Exostosis (osteoma) of the ear Disease
Ceruminous adenoma Disease
Ceruminous adenocarcinoma Disease
Squamous cell carcinoma of the external auditory canal Disease
Otosclerosis Disease
Cholesteatoma Disease
Middle ear papilloma Disease
Vestibular schwannoma Disease
Middle ear neuroendocrine tumour Disease
Endolymphatic sac tumour Disease
Middle ear squamous cell carcinoma Disease
Middle ear adenocarcinoma Disease
Lipomas Disease
Liposarcomas Disease
Nodular fasciitis Disease
Desmoid fibromatosis Disease
Solitary fibrous tumour Disease
Low-grade myofibroblastic sarcoma Disease
Inflammatory myofibroblastic tumour Disease
Haemangioma Disease
Epithelioid haemangioma Disease
Lymphangioma Disease
Epithelioid haemangioendothelioma Disease
Kaposi sarcoma Disease
Angiosarcoma Disease
Myofibroma Disease
Leiomyoma Disease
EBV-associated smooth muscle tumour Disease
Smooth muscle tumour of uncertain malignant potential Disease
Leiomyosarcoma Disease
Rhabdomyoma Disease
Rhabdomyosarcomas Disease
Chondroma Disease
Neurofibroma Disease
Schwannoma Disease
Neuromas Disease
Malignant peripheral nerve sheath tumour Disease
Phosphaturic mesenchymal tumour Disease
Myxoma Disease
Extraskeletal myxoid chondrosarcoma Disease
Synovial sarcoma Disease
GLI1-altered soft tissue tumour Disease
Undifferentiated sarcoma Disease
Ewing sarcoma Disease
Reactive lymphoid hyperplasia Disease
EBV-positive mucocutaneous ulcer Disease
IgG4-related disease Disease
Extramedullary myeloid sarcoma Disease
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) Disease
Mantle cell lymphoma Disease
Follicular lymphoma Disease
Paediatric-type follicular lymphoma Disease
Large B-cell lymphoma with IRF4 rearrangement Disease
Diffuse large B-cell lymphoma Disease
Burkitt lymphoma Disease
Plasmacytoma Disease
Plasmablastic lymphoma Disease
T-lymphoblastic leukaemia/lymphoma Disease
Primary mucosal CD30-positive T-cell lymphoproliferative disorder Disease
Extranodal NK/T-cell lymphoma Disease
Hodgkin lymphoma Disease
Juvenile xanthogranuloma Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Langerhans cell histiocytosis Disease
Follicular dendritic cell sarcoma Disease
Mucosal melanoma Disease
Ranula Disease
Lymphoepithelial cyst Disease
Branchial cleft cyst Disease
Thyroglossal duct cyst Disease
Dermoid and teratoid cysts Disease
Branchioma Disease
Heterotopia-associated carcinoma Disease
Squamous carcinoma of unknown primary site Disease
Germ cell tumours of the head and neck Disease
Metastases to the head and neck region Disease
Neuroendocrine tumour Disease
Ectopic or invasive PitNET / pituitary adenoma Disease
Small cell neuroendocrine carcinoma Disease
Large cell neuroendocrine carcinoma Disease
Merkel cell carcinoma Disease
Head and neck paraganglioma Disease
Naevoid basal cell carcinoma syndrome (Gorlin syndrome) Disease
Neurofibromatosis type 1 Disease
Familial adenomatous polyposis and Gardner syndrome Disease
Brooke-Spiegler syndrome Disease
Cowden syndrome Disease
Familial paraganglioma syndromes Disease
Multiple endocrine neoplasia type 2 Disease
Hyperparathyroidism-jaw tumour syndrome Disease
Li-Fraumeni syndrome Disease
Fanconi anaemia Disease
Dyskeratosis congenita Disease
Ataxia-telangiectasia Disease
Bloom syndrome Disease
Von Hippel-Lindau syndrome Disease
Tuberous sclerosis Disease


Retrieved from "https://ccga.io/index.php?title=HAN5:Volunteer_Assignments_and_Opportunities&oldid=14258"